Americana Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$501K Buy
+2,208
New +$393K 0.01% 403
2020
Q1
– Sell
-25
Closed -$3K – 188
2019
Q4
$3K Buy
+25
New +$3.46K ﹤0.01% 522

Other funds holding CRL

Americana Partners's CRL Position: Q2 2026 in Review

Americana Partners opened a new position in Charles River Laboratories (CRL) in Q2 2026: 2,208 shares worth $501K. The stake represents 0.01% of the portfolio and ranks #403 among its holdings. This is a return to the name: Americana Partners previously reported a position in CRL as recently as Q4 2019.

Americana Partners first reported a position in CRL in Q4 2019 and has held it in 2 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Americana Partners held 2,208 shares of Charles River Laboratories worth $501K as of Q2 2026.
  • Charles River Laboratories was a new Americana Partners position in Q2 2026.
  • Charles River Laboratories made up 0.01% of Americana Partners's portfolio in Q2 2026, its #403 holding.
  • Americana Partners first reported a position in Charles River Laboratories in Q4 2019 and has held it in 2 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.